About this Research Topic
In this Research Topic we ask the question - which insights have we learned on cardiovascular disease in diabetes and what more can we gain from advanced cardiovascular imaging in the future?
The connection between diabetes and risk of cardiovascular disease is clear and concerning; individuals with diabetes are at least two times more likely to develop cardiovascular disease, which is the leading cause of morbidity and mortality in diabetes. Diabetes itself confers an independent risk of cardiovascular disease, but conditions that often coexist with diabetes such as hypertension and dyslipidemia are also clear risk factors.
In recent years, multimodal and hybrid imaging techniques have been improved and developed into the new frontier of medical imaging with the possibility to overcome restrictions of single modalities and to acquire physiological and pathophysiological measurements within an accurate anatomical framework. These non-invasive imaging methods can directly assess both function and morphology of the heart and vessels and have the capacity to redefine our understanding of cardiovascular disease, to improve the pathological understanding, to refine patient risk stratification and to select patients for targeted therapies. Moreover, studies using advanced imaging has the potential to improve our understanding of the cardiovascular mode of action of novel therapies.
Therefore, in this Research Topic, we welcome original research articles (including meta-analyses) and review papers, which deal with topics related to diabetes and advanced imaging of cardiovascular disease. Advanced imaging is broadly defined and includes MR, CT, PET and echocardiography. We welcome both clinical and translational research articles.
-----
Conflict of interest statement: Dr. Bernt Johan von Scholten is currently working full time at Novo Nordisk A/S and owns shares in Novo Nordisk A/S. This affiliation is not considered to be a competing interest in relation to this research topic.
The connection between diabetes and risk of cardiovascular disease is clear and concerning; individuals with diabetes are at least two times more likely to develop cardiovascular disease, which is the leading cause of morbidity and mortality in diabetes. Diabetes itself confers an independent risk of cardiovascular disease, but conditions that often coexist with diabetes such as hypertension and dyslipidemia are also clear risk factors.
In recent years, multimodal and hybrid imaging techniques have been improved and developed into the new frontier of medical imaging with the possibility to overcome restrictions of single modalities and to acquire physiological and pathophysiological measurements within an accurate anatomical framework. These non-invasive imaging methods can directly assess both function and morphology of the heart and vessels and have the capacity to redefine our understanding of cardiovascular disease, to improve the pathological understanding, to refine patient risk stratification and to select patients for targeted therapies. Moreover, studies using advanced imaging has the potential to improve our understanding of the cardiovascular mode of action of novel therapies.
Therefore, in this Research Topic, we welcome original research articles (including meta-analyses) and review papers, which deal with topics related to diabetes and advanced imaging of cardiovascular disease. Advanced imaging is broadly defined and includes MR, CT, PET and echocardiography. We welcome both clinical and translational research articles.
-----
Conflict of interest statement: Dr. Bernt Johan von Scholten is currently working full time at Novo Nordisk A/S and owns shares in Novo Nordisk A/S. This affiliation is not considered to be a competing interest in relation to this research topic.
Keywords: diabetes, Cardiovascular disease, Advanced imaging, Risk stratification, Therapeutic strategies
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
